DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines

被引:49
作者
Kawamoto, Ken [2 ]
Hirata, Hiroshi [2 ]
Kikuno, Nobuyuki [2 ]
Tanaka, Yuichiro [2 ]
Nakagawa, Masayuki [3 ]
Dahiya, Rajvir [1 ,2 ]
机构
[1] Vet Affairs Med Ctr, Urol Res Ctr 112F, Dept Urol, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Sch Med, San Francisco, CA 94121 USA
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan
关键词
sFRP2; gene; Wnt antagonist; DNA methylation; histone modification; renal cell carcinoma;
D O I
10.1002/ijc.23514
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Secreted frizzled-related protein 2 (sFRP2) is a negative modulator of the Wingless-type (Wnt) signaling pathway, and shown to be inactivated in renal cell carcinoma (RCC). However, the molecular mechanism of silencing of sFRP2 is not fully understood. Our study was designed to elucidate the silencing mechanism of sFRP2 in RCC. Expression of sFRP2 was examined in 20 pairs of primary cancers by immunohistochemistry. Kidney cell lines (HK-2, Caki-1, Caki-2, A-498 and ACHN) were analyzed for sFRP2 expression using real-time RT-PCR and Western blotting. The methylation status at 46 CpG sites of the 2 CpG islands in the sFRP2 promoter was characterized by bisulfite DNA sequencing. Histone modifications were assessed by chromatin immunoprecipitation (ChIP) assay using antibodies against AcH3, AcH4, H3K4 and H3K9. sFRP2 was frequently repressed in primary cancers and in RCC cells. The majority of sFRP2 negative cells had a methylated promoter. Meanwhile, sFRP2 expression was repressed by a hypomethylated promoter in Caki-1 cells, and these cells had a repressive histone modification at the promoter. In Caki-1 cells, sFRP2 was reactivated by trichostatin A (TSA). Repressive histone modifications were also observed in RCC cells with hypermethylated promoters, but sFRP2 was reactivated only by 5-aza-2'-deoxycytidine (DAC) and not by TSA. However, the activation of the silenced sFRP2 gene could be achieved in all cells using a combination of DAC and TSA. This is the first report indicating that aberrant DNA methylation and histone modifications work together to silence the sFRP2 gene in RCC cells. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:535 / 542
页数:8
相关论文
共 46 条
  • [31] Nguyen CT, 2002, CANCER RES, V62, P6456
  • [32] Frequent epigenetic inactivation of SFRP genes and constitutive activation of Wnt signaling in gastric cancer
    Nojima, M.
    Suzuki, H.
    Toyota, M.
    Watanabe, Y.
    Maruyama, R.
    Sasaki, S.
    Sasaki, Y.
    Mita, H.
    Nishikawa, N.
    Yamaguchi, K.
    Hirata, K.
    Itoh, F.
    Tokino, T.
    Mori, M.
    Imai, K.
    Shinomura, Y.
    [J]. ONCOGENE, 2007, 26 (32) : 4699 - 4713
  • [33] Park WH, 2003, INT J ONCOL, V22, P1129
  • [34] DNA methylation, chromatin inheritance, and cancer
    Rountree, MR
    Bachman, KE
    Herman, JG
    Baylin, SB
    [J]. ONCOGENE, 2001, 20 (24) : 3156 - 3165
  • [35] Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer
    Soejima, H
    Nakagawachi, T
    Zhao, W
    Higashimoto, K
    Urano, T
    Matsukura, S
    Kitajima, Y
    Takeuchi, M
    Nakayama, M
    Oshimura, M
    Miyazaki, K
    Joh, K
    Mukai, T
    [J]. ONCOGENE, 2004, 23 (25) : 4380 - 4388
  • [36] Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer
    Suzuki, H
    Watkins, DN
    Jair, KW
    Schuebel, KE
    Markowitz, SD
    Chen, WD
    Pretlow, TP
    Bin Yang,
    Akiyama, Y
    van Engeland, M
    Toyota, M
    Tokino, T
    Hinoda, Y
    Imai, K
    Herman, JG
    Baylin, SB
    [J]. NATURE GENETICS, 2004, 36 (04) : 417 - 422
  • [37] A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer
    Suzuki, H
    Gabrielson, E
    Chen, W
    Anbazhagan, R
    van Engeland, M
    Weijenberg, MP
    Herman, JG
    Baylin, SB
    [J]. NATURE GENETICS, 2002, 31 (02) : 141 - 149
  • [38] Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection
    Urakami, S
    Shiina, H
    Enokida, H
    Kawakami, T
    Kawamoto, K
    Hirata, H
    Tanaka, Y
    Kikuno, N
    Nakagawa, M
    Igawa, M
    Dahiya, R
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (07) : 2109 - 2116
  • [39] Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/β-catenin signaling pathway
    Urakami, S
    Shiina, H
    Enokida, H
    Kawakami, T
    Tokizane, T
    Ogishima, T
    Tanaka, Y
    Li, LC
    Ribeiro, LA
    Terashima, M
    Kikuno, N
    Adachi, H
    Yoneda, T
    Kishi, H
    Shigeno, K
    Konety, BR
    Igawa, M
    Dahiya, R
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (02) : 383 - 391
  • [40] Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA
    Urakami, Shinji
    Shiina, Hiroaki
    Enokida, Hideki
    Hirata, Hiroshi
    Kawamoto, Ken
    Kawakami, Toshifumi
    Kikuno, Nobuyuki
    Tanaka, Yuichiro
    Majid, Shahana
    Nakagawa, Masayuki
    Igawa, Mikio
    Dahiya, Rajvir
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (23) : 6989 - 6997